TMV-018

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTMV-018
Drug Alias NameTMV-018
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionThymidylate synthase inhibitorsDNA synthesis inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThemis Bioscience Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThemis Bioscience Gmbh
Active IndicationsN/A
Inactive IndicationsGastrointestinal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A